nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A brief report on incidence, radiographic feature and prognostic significance of brain MRI changes after anti-PD-1/PD-L1 therapy in advanced non-small cell lung cancer
|
Ni, Jianjiao |
|
|
71 |
5 |
p. 1275-1280 |
artikel |
2 |
Assessment of immune status of laryngeal squamous cell carcinoma can predict prognosis and guide treatment
|
Wang, Xueying |
|
|
71 |
5 |
p. 1199-1220 |
artikel |
3 |
Construction and validation of a novel immune and tumor mutation burden-based prognostic model in lung adenocarcinoma
|
Zhou, Bolun |
|
|
71 |
5 |
p. 1183-1197 |
artikel |
4 |
Correction to: Hepatotoxicity associated with PD-1 blockade antibodies in cancer patients co-infected with hepatitis B virus
|
Lin, Zuan |
|
|
71 |
5 |
p. 1257 |
artikel |
5 |
Defective NK cell expansion, cytotoxicity, and lack of ability to differentiate tumors from a pancreatic cancer patient in a long term follow-up: implication in the progression of cancer
|
Kaur, Kawaljit |
|
|
71 |
5 |
p. 1033-1047 |
artikel |
6 |
Effects of combination treatment with durvalumab plus tremelimumab on the tumor microenvironment in non-small-cell lung carcinoma
|
Cheng, Li |
|
|
71 |
5 |
p. 1167-1181 |
artikel |
7 |
Efficacy and mechanism of the anti-CD38 monoclonal antibody Daratumumab against primary effusion lymphoma
|
Panaampon, Jutatip |
|
|
71 |
5 |
p. 1017-1031 |
artikel |
8 |
Efficacy and safety of atezolizumab, in combination with etoposide and carboplatin regimen, in the first-line treatment of extensive-stage small-cell lung cancer: a single-center experience
|
Lee, Seoyoung |
|
|
71 |
5 |
p. 1093-1101 |
artikel |
9 |
EGFR mutation status in non-small cell lung cancer receiving PD-1/PD-L1 inhibitors and its correlation with PD-L1 expression: a meta-analysis
|
Yang, Huimin |
|
|
71 |
5 |
p. 1001-1016 |
artikel |
10 |
Hepatotoxicity associated with PD-1 blockade antibodies in cancer patients co-infected with hepatitis B virus
|
Lin, Zuan |
|
|
71 |
5 |
p. 1247-1255 |
artikel |
11 |
Highly differential count of circulating and tumor infiltrating immune cells in patients with non-HCV/non-HBV hepatocellular carcinoma
|
Schoenberg, Markus Bo |
|
|
71 |
5 |
p. 1103-1113 |
artikel |
12 |
Immune checkpoint CD155 promoter methylation profiling reveals cancer-associated behaviors within breast neoplasia
|
Triki, Hana |
|
|
71 |
5 |
p. 1139-1155 |
artikel |
13 |
Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival
|
Haddad, Tyler C. |
|
|
71 |
5 |
p. 1157-1165 |
artikel |
14 |
Lenvatinib with or without immune checkpoint inhibitors for patients with unresectable hepatocellular carcinoma in real-world clinical practice
|
Chen, Kang |
|
|
71 |
5 |
p. 1063-1074 |
artikel |
15 |
LncRNA MIR155HG induces M2 macrophage polarization and drug resistance of colorectal cancer cells by regulating ANXA2
|
Zhou, Lin |
|
|
71 |
5 |
p. 1075-1091 |
artikel |
16 |
Loss of cancer cell STAT1 improves response to radiation therapy and promotes T cell activation in head and neck squamous cell carcinoma
|
Knitz, Michael W. |
|
|
71 |
5 |
p. 1049-1061 |
artikel |
17 |
MAIT cells accumulate in ovarian cancer-elicited ascites where they retain their capacity to respond to MR1 ligands and cytokine cues
|
Yao, Tony |
|
|
71 |
5 |
p. 1259-1273 |
artikel |
18 |
Sharpening up tumor microenvironment to enhance the efficacy of immune checkpoint blockade on head and neck cancer using a CpG-oligodeoxynucleotide
|
Tseng, Jen-Chih |
|
|
71 |
5 |
p. 1115-1128 |
artikel |
19 |
The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: a single-center, retrospective study
|
Fukuhara, Mitsuro |
|
|
71 |
5 |
p. 1129-1137 |
artikel |
20 |
The Crohn’s-like lymphoid reaction density: a new artificial intelligence quantified prognostic immune index in colon cancer
|
Zhao, Minning |
|
|
71 |
5 |
p. 1221-1231 |
artikel |
21 |
The intestinal flora of patients with GHPA affects the growth and the expression of PD-L1 of tumor
|
Nie, Ding |
|
|
71 |
5 |
p. 1233-1245 |
artikel |